A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma. This is an ASCO Meeting Abstract from the 2018 ASCO ...
CD8⁺ T cells respond to short peptides bound to MHC class I molecules. Although most antigenic proteins contain many sequences that could bind to MHC class I, few of these peptides actually stimulate ...
SEATTLE — The genetic vulnerability to psoriasis and related autoimmune diseases may be traceable to evolutionary pressure to resist ancient infections by retroviruses. The theory is that variations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback